28489511Edelman MJ, Wang X, Hodgson L, Cheney RT, Baggstrom MQ, Thomas SP, Gajra A, Bertino E, Reckamp KL, Molina J, Schiller JH, Mitchell-Richards K, Friedman PN, Ritter J, Milne G, Hahn OM, Stinchcombe TE, Vokes EE, Alliance for Clinical Trials in OncologyJournal of clinical oncology : official journal of the American Society of Clinical OncologyAntineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclooxygenase 2; Lung NeoplasmsCarboplatin; Celecoxib; Cyclooxygenase 2 Inhibitors; Dinoprostone; Disease-Free Survival; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasm Staging; Pemetrexed; Survival RatePhase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance). J Clin Oncol. 2017 Jul 01; 35(19):2184-2192.J Clin Oncol2017-05-10T00:00:002017Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000971Procedures30624340.476235Antineoplastic Combined Chemotherapy ProtocolsAuthorship 10411818Authorship 104031160.1551470.1551472authors10.2517has subject areaD004311Procedures33818220.708936Double-Blind MethodD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD009367Concepts & IdeasProcedures34719320.670065Neoplasm StagingD008175Disorders32822600.404525Lung NeoplasmsD005260Physiology1992444050.191167FemaleD006801Living Beings2262862810.130052HumansD015232Chemicals & Drugs51690.978724DinoprostoneD008297Physiology1931408600.201617MaleD016190Chemicals & Drugs802860.908369CarboplatinMedicine-Hematology and OncologyD052246Chemicals & Drugs30330.984784Cyclooxygenase 2 InhibitorsD018288Disorders511340.922177Carcinoma, Small CellD051546Chemicals & Drugs57990.960033Cyclooxygenase 2D015996Concepts & Ideas45518560.724887Survival RateD00006843728760.971124PemetrexedD00006857918310.980778CelecoxibD018572Concepts & Ideas25812030.792696Disease-Free SurvivalMedicineUniversity of ChicagoEverett E.VokesEverett E. Vokes41.78927490000000-87.601250000000001920Vokes, Everett E.ProfessorOlwenHahnOlwen Hahn41.78927490000000-87.60125000000000534Hahn, OlwenAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professor